Basics Korro Bio, Inc. IPO Date: October 4, 2019 Sector: Healthcare Industry: Biotech Market Cap: $66.11M Activated in VL: True Average Daily Range Avg Daily Range: $0.95 | 4.44% Avg Daily Range (30 D): $1.01 | 4.58% Avg Daily Range (90 D): $1.54 | 5.39% Institutional Daily Volume Avg Daily Volume: .3M Avg Daily Volume (30 D): .67M Avg Daily Volume (90 D): .35M Trade Size Avg Trade Size (Sh.): 121 Avg Trade Size (Sh.) (30 D): 88 Avg Trade Size (Sh.) (90 D): 68 Institutional Trades Total Inst.Trades: 305 Avg Inst. Trade: $1.87M Avg Inst. Trade (30 D): $1.11M Avg Inst. Trade (90 D): $.99M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.48M Avg Closing Trade (30 D): $.94M Avg Closing Trade (90 D): $.84M Avg Closing Volume: 125.21K     News Mar 14, 2025 @ 12:00 PM KRRO-110 Receives Orphan Drug Designation from U.S... Source: N/A Nov 8, 2024 @ 7:34 AM 4 Biotech Stocks With AI, Machine Learning Prowess... Source: Professor Ari Zoldan Sep 19, 2024 @ 10:50 AM Novo Nordisk Just Took a $530 Million Step Onto Mo... Source: The Motley Fool May 20, 2024 @ 6:30 PM Korro Presents Additional Preclinical Data for KRR... Source: Korro Bio, Inc. May 14, 2024 @ 8:01 PM Korro Reports First Quarter 2024 Financial Results... Source: Korro Bio, Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.92 $-2.74 $-2.49 Diluted EPS $-1.92 $-2.74 $-2.49 Revenue $ 1.09M $ 1.46M $ 2.55M Gross Profit $ $ $ Net Income / Loss $ -18.06M $ -25.77M $ -23.39M Operating Income / Loss $ -19.24M $ -27.2M $ -25.02M Cost of Revenue $ $ $ Net Cash Flow $ -9.46M $ -30.53M $ 8.5M PE Ratio